Literature DB >> 9292813

Transient suppression of endogenous cortisol production after intraarticular steroid therapy for chronic arthritis in children.

H I Huppertz1, H Pfüller.   

Abstract

OBJECTIVE: To assess the effect on endogenous cortisol production of administration of intraarticular steroids for chronic arthritis in children and adolescents.
METHODS: We examined 22 children with chronic arthritis who received intraarticular steroid injection. The morning peak cortisol concentration was measured in saliva before and several days to weeks after steroid injection. In 7 children cortisol concentrations were measured at 4 pm and 8 pm as well. In one girl the hypothalamic-pituitary-adrenal axis was tested using the corticotropin releasing hormone stimulation test.
RESULTS: After steroid injection there was suppression of endogenous cortisol production that lasted 10 to 30 days. During this period the circadian rhythm of cortisol production and the hypothalamic-pituitary-adrenal axis were disturbed.
CONCLUSION: After intraarticular steroid injection children show transient suppression of endogenous cortisol production. It is not known whether this might place them at risk from stress induced acute adrenal insufficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292813

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  The effect of intra-articular injection of betamethasone acetate/betamethasone sodium phosphate on blood glucose levels in controlled diabetic patients with symptomatic osteoarthritis of the knee.

Authors:  George Habib; Ahmed Safia
Journal:  Clin Rheumatol       Date:  2008-10-14       Impact factor: 2.980

Review 2.  Intra-articular glucocorticoid injections and their effect on hypothalamic-pituitary-adrenal (HPA)-axis function.

Authors:  Philip C Johnston; M Cecilia Lansang; Soumya Chatterjee; Laurence Kennedy
Journal:  Endocrine       Date:  2014-09-03       Impact factor: 3.633

3.  Cushing's syndrome and adrenal insufficiency after intradermal triamcinolone acetonide for keloid scars.

Authors:  Martijn J J Finken; Dick Mul
Journal:  Eur J Pediatr       Date:  2010-02-26       Impact factor: 3.183

4.  Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis.

Authors:  P Tynjälä; P Lahdenne; P Vähäsalo; H Kautiainen; V Honkanen
Journal:  Ann Rheum Dis       Date:  2006-01-31       Impact factor: 19.103

Review 5.  Intra-articular corticosteroid injections in juvenile idiopathic arthritis.

Authors:  A G Cleary; H D Murphy; J E Davidson
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

Review 6.  Glucocorticoid treatment in juvenile idiopathic arthritis.

Authors:  Ezgi Deniz Batu
Journal:  Rheumatol Int       Date:  2018-10-01       Impact factor: 2.631

7.  Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study.

Authors:  Ashley P Jones; Dannii Clayton; Gloria Nkhoma; Frances C Sherratt; Matthew Peak; Simon R Stones; Louise Roper; Bridget Young; Flora McErlane; Tracy Moitt; Athimalaipet V Ramanan; Helen E Foster; Paula R Williamson; Samundeeswari Deepak; Michael W Beresford; Eileen M Baildam
Journal:  Health Technol Assess       Date:  2020-07       Impact factor: 4.014

8.  Intra-articular methylprednisolone acetate injection at the knee joint and the hypothalamic-pituitary-adrenal axis: a randomized controlled study.

Authors:  George Habib; Adel Jabbour; Suheil Artul; Geries Hakim
Journal:  Clin Rheumatol       Date:  2013-08-28       Impact factor: 2.980

Review 9.  Systemic effects of intra-articular corticosteroids.

Authors:  George S Habib
Journal:  Clin Rheumatol       Date:  2009-02-28       Impact factor: 2.980

Review 10.  Intra-articular corticosteroids in the treatment of juvenile idiopathic arthritis: Safety, efficacy, and features affecting outcome. A comprehensive review of the literature.

Authors:  Alisa Carman Gotte
Journal:  Open Access Rheumatol       Date:  2009-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.